medmix AG reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was CHF 250.6 million compared to CHF 228.3 million a year ago. Net income was CHF 23.8 million compared to CHF 22.7 million a year ago. Basic earnings per share from continuing operations was CHF 0.58 compared to CHF 0.55 a year ago. Diluted earnings per share from continuing operations was CHF 0.58 compared to CHF 0.55 a year ago.